Gene therapy market to hit $6,205.85 Mn by 2026 from $393.35 Mn in 2018, at a CAGR of 34.8%. Significant improvements in vector engineering, delivery, and safety have placed viral vector-based therapy at the forefront of modern medicine. ... Another gene therapy designed for so-called bubble boy syndrome also hit the market, followed recently by another for an inherited form of blindness. 0 comments. According to The Journal of Gene Medicine, just over 2,700 gene therapy clinical trials have been undertaken in 38 countries around the world as of 2018 2. A variety of efforts are underway to apply gene therapy to cancer treatment. Gene therapy alters the genetic instructions within an individual’s cells. Gene therapy is being investigated to treat a variety of cancers and genetic diseases. Applications of viral vectors have found an encouraging new beginning in gene therapy in recent years. Gene therapy is one of the most attractive fields in medicine. China is expected to grow highest in the Asia-Pacific region. Monday 02 April 2018 14:01. What to Expect from Gene Therapy Drugs in 2018 Written by Shawn Radcliffe — Updated on September 24, 2018 A new treatment for blindness has brought gene therapy … Most are in early, exploratory stages, where they’re being studied in … A gene is a sequence of DNA — pictured above. The reports flooded in to the US National Institutes of Health (NIH), after they asked researchers to provide information that might explain the death of Jesse Gelsinger during a gene therapy trial last September. Hundreds of failed genetic therapy experiments, including a number of deaths, came to light in the US this week. Genuine potential for success Victoria Gray's recovery from sickle cell disease, which had caused her painful seizures, came in a year of breakthroughs in one of the hottest areas of medical research—gene therapy.